Table A1:
Descriptive characteristics of the study sample for the analysis of the first gap in care and death prior to the first gap.
| Passively ascertained outcome | p-Value | |||
|---|---|---|---|---|
| In care | Death | LTCa | ||
| (n=17,619) | (n=1,979) | (n=18,892) | ||
| n(%) | n(%) | n(%) | ||
| Outreach | ||||
| Not attempted | 0 (−) | 0 (−) | 14,774 (78.2) | - |
| Not found | 0 (−) | 0 (−) | 1,580 (8.4) | |
| Found | 0 (−) | 0 (−) | 2,538 (13.4) | |
| True outcomeb | ||||
| Death | 0 (−) | 0 (−) | 491 (19.3) | - |
| Gap in care | 0 (−) | 0 (−) | 2,047 (80.7) | |
| Gender | ||||
| Female & non-pregnantc | 9,412 (58.9) | 726 (43.1) | 8,058 (51.8) | <0.001 |
| Female & pregnantc | 1,076 (6.7) | 32 (1.9) | 1,190 (7.6) | |
| Male | 5,488 (34.4) | 926 (55.0) | 6,320 (40.6) | |
| HIV status disclosed | ||||
| No | 6,269 (35.6) | 670 (33.9) | 6,972 (36.9) | 0.003 |
| Yes | 11,350 (64.4) | 1,309 (66.1) | 11,920 (63.1) | |
| Travel time to clinic | ||||
| <30′ | 4,570 (25.9) | 480 (24.3) | 4,752 (25.2) | <0.001 |
| 30–59′ | 6,153 (34.9) | 679 (34.3) | 5,936 (31.4) | |
| 1–2 h | 4,346 (24.7) | 482 (24.4) | 4,659 (24.7) | |
| 2 + h | 2,550 (14.5) | 338 (17.1) | 3,545 (18.8) | |
| Level of care | ||||
| Primary | 5,777 (32.8) | 649 (32.8) | 5,814 (30.8) | <0.001 |
| Secondary | 9,561 (54.3) | 1,176 (59.4) | 9,967 (52.8) | |
| Tertiary | 2,281 (12.9) | 154 (7.8) | 3,111 (16.5) | |
| Median (IQR) | Median (IQR) | Median (IQR) | p-Value | |
| Aged, years | 37.9 (32.0, 45.4) | 37.8 (31.7, 45.2) | 36.0 (30.3, 43.1) | <0.001 |
| CD4d, cells/μL | 186 (113, 263) | 106 (52, 179) | 155 (83, 234) | <0.001 |
| Outreach worker ratioe (×100) | 5.0 (3.6, 5.9) | 5.0 (4.0, 5.9) | 5.0 (4.0, 5.9) | <0.001 |
a
Lost to clinic.
b
Ascertained through outreach.
c
At or prior to ART initiation.
d
At ART initiation.
e
# of outreach workers to total daily # of adult patients.